| DC Field | Value | Language |
|---|
| dc.contributor.author | Maltsev, D. V. | - |
| dc.contributor.author | Adzhienko, K. I. | - |
| dc.contributor.author | Perfiliev, M. A. | - |
| dc.contributor.author | Nekrasov, D. A. | - |
| dc.contributor.author | Maltseva, M. O. | - |
| dc.date.accessioned | 2026-10-13T08:39:49Z | - |
| dc.date.available | 2026-10-13T08:39:49Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | Evaluation of the anxiolytic properties of benzimidazole-2-thioethanones, 2-alkylthio- and 2-alkylsulfonylbenzimidazoles / D.V. Maltsev, K.I. Adzhienko, M.A. Perfiliev [et al.] // Research Results in Pharmacology. - 2026. - Vol.12, №3.-P. 91-103. - DOI: 10.18413/rrpharmacology.12.1156. - Refer.: p. 101-102. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67137 | - |
| dc.description.abstract | Fabomotizole is an anxyolytic drug produced in Russia, a 2-mercaptobenzimidazole derivative. The pleiotropic effects of the benzimidazole scaffold, combined with proven neuropsychotropic properties, make fabomotizole a promising target for the synthesis of its analogs to obtain new derivatives with pronounced biological activity | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | open Field | ru |
| dc.subject | Light/Dark Box | ru |
| dc.subject | 2-mercaptobenzimidazole | ru |
| dc.subject | quantum chemistry | ru |
| dc.subject | fabomotizol | ru |
| dc.subject | phenazepam | ru |
| dc.subject | etifoxine | ru |
| dc.title | Evaluation of the anxiolytic properties of benzimidazole-2-thioethanones, 2-alkylthio- and 2-alkylsulfonylbenzimidazoles | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 3
|
